Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation
Management of acute respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a challenge for the staff on intensive-care units (ICU’s) around the world. Many of these patients are treated with invasive ventilation. Sometimes, the occurrence...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Critical Care |
| Online Access: | http://dx.doi.org/10.1155/2022/6559385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849469523075268608 |
|---|---|
| author | Julian Umlauf Stefanie Eilenberger Oliver Spring |
| author_facet | Julian Umlauf Stefanie Eilenberger Oliver Spring |
| author_sort | Julian Umlauf |
| collection | DOAJ |
| description | Management of acute respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a challenge for the staff on intensive-care units (ICU’s) around the world. Many of these patients are treated with invasive ventilation. Sometimes, the occurrence of pneumothorax and/or pneumomediastinum can complicate the course of the disease because initiation of invasive ventilation might be fatal in those patients. Venovenous extracorporal membrane oxygenation (vv-ECMO) is increasingly used to prevent patients with severe ARDS from hypoxia. However, clear recommendations for or against the initiation of vv-ECMO in awake patients are currently lacking. We present the case of a 42-year-old patient with COVID-19-associated severe ARDS, pneumothorax, and pneumomediastinum. To preserve sufficient oxygenation and to avoid invasive ventilation, we implanted a vv-ECMO while the patient was awake. The patient recovered and was discharged home 41 days after transfer to our hospital. We therefore suggest that awake implantation of vv-ECMO might be useful in a subgroup of patients with severe ARDS caused by SARS-CoV-2. However, further evidence is needed to verify our hypothesis. |
| format | Article |
| id | doaj-art-fd4c4ea6edd24da9a18253f24c63a6c8 |
| institution | Kabale University |
| issn | 2090-6439 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Critical Care |
| spelling | doaj-art-fd4c4ea6edd24da9a18253f24c63a6c82025-08-20T03:25:26ZengWileyCase Reports in Critical Care2090-64392022-01-01202210.1155/2022/6559385Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO ImplantationJulian Umlauf0Stefanie Eilenberger1Oliver Spring2Department of Anaesthesia and Surgical Intensive Care MedicineDepartment of Anaesthesia and Surgical Intensive Care MedicineDepartment of Anaesthesia and Surgical Intensive Care MedicineManagement of acute respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a challenge for the staff on intensive-care units (ICU’s) around the world. Many of these patients are treated with invasive ventilation. Sometimes, the occurrence of pneumothorax and/or pneumomediastinum can complicate the course of the disease because initiation of invasive ventilation might be fatal in those patients. Venovenous extracorporal membrane oxygenation (vv-ECMO) is increasingly used to prevent patients with severe ARDS from hypoxia. However, clear recommendations for or against the initiation of vv-ECMO in awake patients are currently lacking. We present the case of a 42-year-old patient with COVID-19-associated severe ARDS, pneumothorax, and pneumomediastinum. To preserve sufficient oxygenation and to avoid invasive ventilation, we implanted a vv-ECMO while the patient was awake. The patient recovered and was discharged home 41 days after transfer to our hospital. We therefore suggest that awake implantation of vv-ECMO might be useful in a subgroup of patients with severe ARDS caused by SARS-CoV-2. However, further evidence is needed to verify our hypothesis.http://dx.doi.org/10.1155/2022/6559385 |
| spellingShingle | Julian Umlauf Stefanie Eilenberger Oliver Spring Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation Case Reports in Critical Care |
| title | Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation |
| title_full | Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation |
| title_fullStr | Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation |
| title_full_unstemmed | Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation |
| title_short | Successful Treatment of a Patient with COVID-19-Induced Severe ARDS, Pneumothorax, and Pneumomediastinum with Awake vv-ECMO Implantation |
| title_sort | successful treatment of a patient with covid 19 induced severe ards pneumothorax and pneumomediastinum with awake vv ecmo implantation |
| url | http://dx.doi.org/10.1155/2022/6559385 |
| work_keys_str_mv | AT julianumlauf successfultreatmentofapatientwithcovid19inducedsevereardspneumothoraxandpneumomediastinumwithawakevvecmoimplantation AT stefanieeilenberger successfultreatmentofapatientwithcovid19inducedsevereardspneumothoraxandpneumomediastinumwithawakevvecmoimplantation AT oliverspring successfultreatmentofapatientwithcovid19inducedsevereardspneumothoraxandpneumomediastinumwithawakevvecmoimplantation |